Skip to content
How to use Judgment tools
  1. Click Tools to open PDF, Print, Tag, Note, Favourite, and CiteSignal.
  2. Use Brief & Ask in the toolbar for the AI Brief and case chat.
  3. Jump to sections with the pills below the help bar.

C.C.E. Vs. Lenec Institute of

C.C.E. vs Lenec Institute of

Type Court Judgment Court Customs Excise and Service Tax Appellate Tribunal CESTAT Mumbai Decided Oct 25, 2005
~2 min read
https://sooperkanoon.com/case/40621

For advocates & juniors · 7-day free trial

Brief this judgment before chambers

Stop skimming 50 pages - get an 18-section AI Brief on this case, ask scoped follow-ups, and find related precedents with Semantic Search. Full trial, no card required.

  • 18-section brief - facts, issues, ratio, relief
  • Ask this case - answers cite the judgment
  • Semantic search - find precedents by meaning
  • Research drawer - sections, cites, related cases

No card required · credentials emailed · Log in if you already have an account

Citation
Court
Customs Excise and Service Tax Appellate Tribunal CESTAT Mumbai
Judge
Decided On
Subject
Service Tax

Case Summary

AI-generated summary - not the official court judgment text.

Service Tax

Key legal issue
Service Tax

Parties & Advocates

Appellant / Petitioner

C.C.E.

Respondent

Lenec Institute of

Excerpt

.....we have heard the id. jt. cdr and perused the records; none appears for the respondents in spite of notice. we find that the product 'sipro syrup' has the following description :-______________________________________________________________ each 5 ml contains______________________________________________________________ferrous giuconate 100 mgsodium ascorbale 37.5 mgniacinamide 25 mgfolic acid 0.5 mgvit b-1 2.5 mgvit b-2 2.5vit b-6 0.75vit b-12 2.5 mg.______________________________________________________________ according to the revenue, the product has no curative effect against any bacterial fungal or viral diseases but only substentiates deficiency in human body and therefore is not treated as medicaments for purpose of classification under chapter 3003.10 but will be properly classifiable as mixtures of vitamins under chapter heading 2936.00. we find that similar issue on similar product had come up before the larger bench of the tribunal in the case of micropure parenterals pvt. ltd. v. cce, mumbai and vide order no. a-583/wzb/05/c.ii dated 5-10-05, it was held that product having fixed dose combination of vitamin b-l, b-5, b-12 like in the present case falls for classification under chapter 30.03. in that case also rival entries were 30.03 and 29.36 as in the present case. larger bench has endorsed the view of the earlier decision of the tribunal in the case of e. merck (india) ltd. v. cce, mumbai .following the ratio of the above larger bench decision, we hold that there is no ground to interfere with the impugned order of the commissioner (appeals) and accordingly uphold the same and reject the appeal.

Full Judgment

1. Revenue is aggrieved by the order of Commissioner (Appeals) who had accepted the respondents' claim for classification of product containing predominance of vitamins and iron, under GET sub-heading 3003.10 as P & P medicaments, rejecting the claim of the Revenue for the classification of the product in question viz. 'Sipro Syrup' under CET sub-heading 2936.00.

2. We have heard the Id. Jt. CDR and perused the records; none appears for the respondents in spite of notice. We find that the product 'Sipro Syrup' has the following description :-______________________________________________________________ Each 5 ml contains______________________________________________________________Ferrous Giuconate 100 mgSodium ascorbale 37.5 mgNiacinamide 25 mgFolic acid 0.5 mgVit B-1 2.5 mgVit B-2 2.5Vit B-6 0.75Vit B-12 2.5 mg.______________________________________________________________ According to the Revenue, the product has no curative effect against any bacterial fungal or viral diseases but only substentiates deficiency in human body and therefore is not treated as medicaments for purpose of classification under Chapter 3003.10 but will be properly classifiable as mixtures of vitamins under Chapter Heading 2936.00. We find that similar issue on similar product had come up before the Larger Bench of the Tribunal in the case of Micropure Parenterals Pvt. Ltd. v. CCE, Mumbai and vide Order No. A-583/WZB/05/C.II dated 5-10-05, it was held that product having fixed dose combination of vitamin B-l, B-5, B-12 like in the present case falls for classification under Chapter 30.03. In that case also rival entries were 30.03 and 29.36 as in the present case. Larger Bench has endorsed the view of the earlier decision of the Tribunal in the case of E. Merck (India) Ltd. v. CCE, Mumbai .

Following the ratio of the above Larger Bench decision, we hold that there is no ground to interfere with the impugned order of the Commissioner (Appeals) and accordingly uphold the same and reject the appeal.

Continue Your Research


AI Briefs · Semantic Search · Save & annotate judgments

Start your 7-day free trial